Committees

Lloyd B. Minor, MD, is a scientist, surgeon, and academic leader. He is the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine and Vice President for Medical Affairs at Stanford University. Dr. Minor also is a professor of Otolaryngology–Head and Neck Surgery and a professor of Bioengineering and of Neurobiology, by courtesy, at Stanford University. As dean, Dr. Minor has had an integral role in setting strategy for the clinical enterprise of Stanford Medicine, an academic medical center that includes the Stanford University School of Medicine, Stanford Health Care, and Stanford Medicine Children’s Health. With his leadership, Stanford Medicine leads the biomedical revolution in Precision Health. His book, “Discovering Precision Health,” describes this shift to more preventive, personalized health care and highlights how biomedical advances are dramatically improving our ability to treat and cure complex diseases. In 2021, Dr. Minor articulated and began realizing a bold vision to transform the future of life sciences at Stanford University and beyond – a multi-decade journey enabled by Precision Health. In August 2023, Dr. Minor was appointed Vice President for Medical Affairs to lead all matters related to health and medicine at Stanford University. Before Stanford, Dr. Minor was provost and senior vice president for academic affairs of Johns Hopkins University. Prior to this appointment in 2009, Dr. Minor served as the Andelot Professor and director (chair) of the Department of Otolaryngology–Head and Neck Surgery in the Johns Hopkins University School of Medicine and otolaryngologist-in-chief of The Johns Hopkins Hospital. With more than 160 published articles and chapters, Dr. Minor is an expert in balance and inner ear disorders perhaps best known for discovering superior canal dehiscence syndrome, a debilitating disorder characterized by sound- or pressure-induced dizziness. He subsequently developed a surgical procedure that corrects the problem and alleviates symptoms. In 2012, Dr. Minor was elected to the National Academy of Medicine.

Dr. Yeung is a highly experienced, world-renowned interventional cardiologist and cardiologist. He has board certification in interventional cardiology, cardiovascular disease, and internal medicine. He completed fellowship training in cardiology. He is the Stanford University School of Medicine Li Ka Shing Professor in Cardiology. He is the past chief of the Stanford Medicine Division of Cardiovascular Medicine. Dr. Yeung provides care for the complete range of cardiovascular conditions such as coronary artery disease and heart valve disease. He performs treatment procedures including transcatheter aortic valve replacement (TAVR), cardiac catheterization, and balloon valvuloplasty. He has conducted numerous research studies as a principal investigator or co-investigator. He has researched the placement of aortic transcatheter valves, use of a novel device to improve ventricular compliance, use of a vascular scaffold to treat coronary artery lesions, and other advances in techniques and technology. He has received grants supporting his research from industry leaders as well as from the National Institutes of Health. Dr. Yeung has published his research findings in more than 300 articles in peer-reviewed journals such as the American Heart Journal, International Journal of Cardiology, and Circulation: Cardiovascular Intervention. He is on the editorial board of the Journal of the American College of Cardiology. He is a reviewer for the Journal of Heart and Lung Transplantation, Journal of Vascular Medicine and Biology, Circulation, New England Journal of Medicine, and Lancet. He was an editor-in-chief of the book Interventional Cardiology and has contributed chapters to many textbooks. Dr. Yeung plays an integral role in training the interventional cardiologists of the future. He has served as chairman of the board of the Internal Medicine Interventional Board Committee. He is a fellow of the American College of Cardiology. He has made invited presentations to his peers worldwide at meetings of the American College of Cardiology, Joint Interventional Meeting, Cardiac Intervention Today, and others. Dr. Yeung holds patents for innovations in cardiac care. His inventions focus on novel solutions in medication delivery to treat arterial sclerosis and vascular injury.

Dr. Yeung is a highly experienced, world-renowned interventional cardiologist and cardiologist. He has board certification in interventional cardiology, cardiovascular disease, and internal medicine. He completed fellowship training in cardiology. He is the Stanford University School of Medicine Li Ka Shing Professor in Cardiology. He is the past chief of the Stanford Medicine Division of Cardiovascular Medicine. Dr. Yeung provides care for the complete range of cardiovascular conditions such as coronary artery disease and heart valve disease. He performs treatment procedures including transcatheter aortic valve replacement (TAVR), cardiac catheterization, and balloon valvuloplasty. He has conducted numerous research studies as a principal investigator or co-investigator. He has researched the placement of aortic transcatheter valves, use of a novel device to improve ventricular compliance, use of a vascular scaffold to treat coronary artery lesions, and other advances in techniques and technology. He has received grants supporting his research from industry leaders as well as from the National Institutes of Health. Dr. Yeung has published his research findings in more than 300 articles in peer-reviewed journals such as the American Heart Journal, International Journal of Cardiology, and Circulation: Cardiovascular Intervention. He is on the editorial board of the Journal of the American College of Cardiology. He is a reviewer for the Journal of Heart and Lung Transplantation, Journal of Vascular Medicine and Biology, Circulation, New England Journal of Medicine, and Lancet. He was an editor-in-chief of the book Interventional Cardiology and has contributed chapters to many textbooks. Dr. Yeung plays an integral role in training the interventional cardiologists of the future. He has served as chairman of the board of the Internal Medicine Interventional Board Committee. He is a fellow of the American College of Cardiology. He has made invited presentations to his peers worldwide at meetings of the American College of Cardiology, Joint Interventional Meeting, Cardiac Intervention Today, and others. Dr. Yeung holds patents for innovations in cardiac care. His inventions focus on novel solutions in medication delivery to treat arterial sclerosis and vascular injury.

Dr. Yeung is a highly experienced, world-renowned interventional cardiologist and cardiologist. He has board certification in interventional cardiology, cardiovascular disease, and internal medicine. He completed fellowship training in cardiology. He is the Stanford University School of Medicine Li Ka Shing Professor in Cardiology. He is the past chief of the Stanford Medicine Division of Cardiovascular Medicine. Dr. Yeung provides care for the complete range of cardiovascular conditions such as coronary artery disease and heart valve disease. He performs treatment procedures including transcatheter aortic valve replacement (TAVR), cardiac catheterization, and balloon valvuloplasty. He has conducted numerous research studies as a principal investigator or co-investigator. He has researched the placement of aortic transcatheter valves, use of a novel device to improve ventricular compliance, use of a vascular scaffold to treat coronary artery lesions, and other advances in techniques and technology. He has received grants supporting his research from industry leaders as well as from the National Institutes of Health. Dr. Yeung has published his research findings in more than 300 articles in peer-reviewed journals such as the American Heart Journal, International Journal of Cardiology, and Circulation: Cardiovascular Intervention. He is on the editorial board of the Journal of the American College of Cardiology. He is a reviewer for the Journal of Heart and Lung Transplantation, Journal of Vascular Medicine and Biology, Circulation, New England Journal of Medicine, and Lancet. He was an editor-in-chief of the book Interventional Cardiology and has contributed chapters to many textbooks. Dr. Yeung plays an integral role in training the interventional cardiologists of the future. He has served as chairman of the board of the Internal Medicine Interventional Board Committee. He is a fellow of the American College of Cardiology. He has made invited presentations to his peers worldwide at meetings of the American College of Cardiology, Joint Interventional Meeting, Cardiac Intervention Today, and others. Dr. Yeung holds patents for innovations in cardiac care. His inventions focus on novel solutions in medication delivery to treat arterial sclerosis and vascular injury.